Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Shockwave Medical Inc

(NASDAQ: SWAV)
Add to Portfolio
+0.28 (+0.66%)
as of Feb 19, 2020

Last 42.79
Change +0.28 (+0.66%)
Open 42.01
Prev. Close 42.51
Today's Range
40.75
43.52
52wk Range
24.58
68.39
Volume 1,326,700
Avg Volume 406,630
Sector SIC-3841 Surgical & Medical Instruments & Apparatus

Perfomance Comparison

Name Today 3-Month 1-Year
SWAV +0.66% +8.11% +40.30%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS -2.70
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 1,255,110
Weighted Alpha +5.68
Standard Deviation +0.26
Profit Margin N/A
Beta N/A

Growth Rates

YTD -2.57%

Opinion

Sell Hold Buy

Recent Headlines

Shockwave Announces Pricing of Public Offering of

GlobeNewswire via COMTEX - Thu Nov 14, 10:00PM EST
Shockwave Medical, Inc. ("Shockwave") (Nasdaq: SWAV) today announced the pricing of its public offering of 2,481,781 shares of its common stock at a price to the public of $36.25 per share. All of the shares are being offered by S(full story)
MS: 56.31 (+0.79), WFC: 47.09 (+0.10), SWAV: 42.79 (+0.28)

Shockwave Announces Proposed Public Offering of Common

GlobeNewswire via COMTEX - Tue Nov 12, 04:13PM EST
Shockwave Medical, Inc. ("Shockwave") (Nasdaq: SWAV) today announced it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. All of the shares of common stock are being offered by Shockwave. (full story)
MS: 56.31 (+0.79), SWAV: 42.79 (+0.28)

Shockwave Medical to Participate in Upcoming Investor

GlobeNewswire via COMTEX - Wed Aug 21, 08:30AM EDT
Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will be participating in (full story)
WFC: 47.09 (+0.10), SWAV: 42.79 (+0.28)

Shockwave Appoints Hajime Tada as General Counsel

GlobeNewswire via COMTEX - Mon Jun 10, 08:00AM EDT
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Hajime(full story)
A: 85.35 (+0.56), SWAV: 42.79 (+0.28)

Growing Global Demand for Non-Invasive Cellulite

PR Newswire via COMTEX - Wed May 29, 08:50AM EDT
Cellulite affects 85% to 90% of all women worldwide and was first described nearly 100 years ago, and has been the bane of women (and men) ever since. But to find a 'cure' or effective 'solution' the cause must be understood. Firs(full story)
SOLY: 12.91 (-0.14), BSX: 43.02 (+0.86), SWAV: 42.79 (+0.28), SESN: 0.84 (-0.02), PFE: 36.23 (-0.09)